ArticleClinics (Sao Paulo, Brazil)2026

Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center.

Barbara Bayeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.